FLUXERGY INC.

Fluxergy Inc. is a medical diagnostic company specializing in multimodal point-of-care diagnostic platforms that integrate molecular testing (PCR), immunochemistry, cytometry, and electrochemistry on a single analyzer. Founded in 2013 and based in Irvine, California, Fluxergy develops automated, sample-to-answer diagnostic systems delivering results in under one hour. The company's open platform ecosystem comprises the Fluxergy Analyzer (the core instrument), proprietary test cards supporting multiplex and multimodal assays, and Fluxergy Works (intuitive software for test execution and result visualization). With over 500 test systems manufactured and 100,000 test cartridges produced, Fluxergy serves healthcare providers, diagnostic laboratories, and veterinary practitioners. The platform addresses the current clinical fragmentation requiring multiple POC devices by consolidating molecular, immunochemistry, cytometry, and electrochemical detection into one cost-effective instrument. Applications include infectious disease diagnostics, sepsis assessment, and veterinary pathogen detection (equine respiratory pathogens, Salmonella, Streptococcus equi). Currently in Series C funding with established OEM partnerships and clinical validation from leading academic institutions and veterinary hospitals.